Aurobindo’s CuraTeQ Expands Biosimilars Deal With Orion For Baltic Countries
Partners Expect To Launch Products Between 2023 And 2026
Aurobindo’s CuraTeQ Biologics has expanded its biosimilar distribution agreement with Finnish Player Orion. After covering the Nordics, Austria, Hungary and Slovenia, the partnering companies have decided to expand to the Baltic countries, with launches slated for between 2023 and 2026.
